Last reviewed · How we verify

NCT06116942

Magnetic Brain Stimulation and Computer-based Motor Training for Rehabilitation After Stroke

Recruiting now NA Last updated 9 November 2023
What this trial tests

NA trial testing Active rTMS in Chronic Stroke in 24 participants. Currently enrolling.

Timeline
8 November 2023
Primary endpoint
19 September 2026
19 September 2027

Quick facts

Lead sponsorMax Planck Institute for Human Cognitive and Brain Sciences
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment24
Start date8 November 2023
Primary completion19 September 2026
Estimated completion19 September 2027
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Max Planck Institute for Human Cognitive and Brain Sciences

Who can join

Adults 20 to 80, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the present clinical trial is to explore whether an innovative technology-based approach can help individuals who have had a stroke and can no longer move their hands with ease. Our approach consists of a combination of two technologies: Transcranial Magnetic Stimulation (TMS) and a Brain-Computer Interface (BCI). The former entails the application of magnetic fields over the head to stimulate the brain preparing it for a better ability to produce movement. The latter consists of measuring brain activity to personalize a type of computer-based training that is designed to increase communication between the brain and the muscles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Active rTMS

Trials testing the same drug.

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other Max Planck Institute for Human Cognitive and Brain Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06116942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing